Translumina Therapeutics, India’s largest domestic player in the coronary stents market, announces the initiation of direct operations in the UAE
October 22, 2024 / News
Media
Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands
June 29, 2023 / News
The acquisition gives access to a patented, innovative, and proven next-generation Drug Coated Balloon (DCB) technology that may revolutionize the scope of complex coronary interventions
Read More
